niquitin mini citrus pressitud loseng
richard bittner ag - nikotiin - pressitud loseng - 2mg 100tk; 2mg 60tk; 2mg 20tk
niquitin mini mint pressitud loseng
richard bittner ag - nikotiin - pressitud loseng - 2mg 100tk; 2mg 20tk; 2mg 60tk
niquitin mini citrus pressitud loseng
richard bittner ag - nikotiin - pressitud loseng - 4mg 100tk; 4mg 60tk
migsun õhukese polümeerikattega tablett
orion corporation - sumatriptaan+naprokseen - õhukese polümeerikattega tablett - 85mg+500mg 9tk
vyvgart
argenx - efgartigimod alfa - myasthenia gravis - immunosupressandid - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.
pyrukynd
agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.
sildenafil g.l. pharma õhukese polümeerikattega tablett
g.l. pharma gmbh - sildenafiil - õhukese polümeerikattega tablett - 20mg 300tk; 20mg 90tk
columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - antineoplastilised ained - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.
diazepam basi süstelahus
laboratorios basi industria farmaceutica s.a. - diasepaam - süstelahus - 5mg 1ml 2ml 50tk